Investor Awareness

HomeAbout Investor AwarenessClient ServicesClient Success StoriesManagement TeamClient ProfilesContact Us



Chicago-based Investor Awareness, Inc., a full service Strategic Management Consulting firm for private and publicly traded companies with customized programs to generate awareness among members of the international financial community.

Since our founding in 1994, Investor Awareness has strategically worked with hundreds of companies in a wide variety of industries. Our hands-on approach helps our clients realize that investors don’t come just from Wall Street, but can be found all over the world. By making relationship building a priority, we have compiled a proprietary database of 69,000 financial industry contacts.

Our staff is not afraid to roll up its sleeves and work hard on behalf of our clients. In fact, many of our colleagues and partners notice that Investor Awareness brings an unprecedented amount of dedication and energy to the tasks at hand, a commitment that impacts both the quality of our relationships and level of results that we deliver.

Investor Awareness recognizes that media and investor relations are intricately connected, and employs a staff with expertise in both areas that work congruently on the entire package. This focus enables us to maintain a consistent message and public image to all audiences.


read more

Company Profiles

Upcoming Events

There are no events to display at this time.
Complete Events List

Tony Schor Entrepreneur


Chicago Now


News and Updates

Onconova Therapeutics Announces License Agreement with Pint Pharma
NEWTOWN, Pa., March 05, 2018 -- Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced that they have entered into a license agreement with Pint Pharma GmbH to commercialize rigosertib, a novel and targeted anti-cancer compound currently in a Phase 3 study for the treatment of MDS, a group of rare hematologic malignancies. Pint Pharma is a European-based pharmaceutical company focused on the development, registration and commercialization of specialty-based treatments for the Latin American market. (full story)

More Articles



  Disclaimer     Financial Glossary

©2017 Investor Awareness, Inc. All rights reserved